Jeffrey L. Garwin
Gründer bei UltraTouch Corp.
Profil
Jeffrey L.
Garwin is the founder and holds the title of President, Secretary & Treasurer at UltraTouch Corp.
which is founded in 1998.
He also held the position of Director at Biomoda, Inc. and Chief Medical Officer at Ritter Pharmaceuticals, Inc. Dr. Garwin received his undergraduate degree from Stanford University and his doctorate from Yale University.
Aktive Positionen von Jeffrey L. Garwin
Unternehmen | Position | Beginn |
---|---|---|
UltraTouch Corp.
UltraTouch Corp. Medical SpecialtiesHealth Technology UltraTouch Corp. develops precision breast palpation technology for documentation of palpation exams in the medical record. It offers Palpagraph, a breast tumor detection device to store the data for the medical record. The company was founded by Jeffrey L. Garwin in 1998 and is headquartered in Paoli, PA. | Gründer | 01.01.1998 |
Ehemalige bekannte Positionen von Jeffrey L. Garwin
Unternehmen | Position | Ende |
---|---|---|
QUALIGEN THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
BIOMODA, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Jeffrey L. Garwin
Yale University | Doctorate Degree |
Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Biomoda, Inc.
Biomoda, Inc. Medical/Nursing ServicesHealth Services Biomoda, inc. operates as an in-vitro diagnostics company. The company was founded on January 3, 1990 and is headquartered in Albuquerque, NM. | Health Services |
UltraTouch Corp.
UltraTouch Corp. Medical SpecialtiesHealth Technology UltraTouch Corp. develops precision breast palpation technology for documentation of palpation exams in the medical record. It offers Palpagraph, a breast tumor detection device to store the data for the medical record. The company was founded by Jeffrey L. Garwin in 1998 and is headquartered in Paoli, PA. | Health Technology |
Ritter Pharmaceuticals, Inc.
Ritter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA. | Health Technology |